Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boots Healthcare Gains Access To U.S. Market Through Clearasil Buy

Executive Summary

Boots Healthcare International views its acquisition of the Clearasil acne prevention and treatment brand as a possible springboard for creating an OTC drug marketing presence in the U.S.
Advertisement

Related Content

Clearasil For Men Uses Anti-Acne Positioning To Enter Men’s Market
Clearasil Anti-Acne Collection Expands With New Forms
Clearasil Launch Aims For Broader Control Of U.S. Skin Care Category
Clearasil Steps Into Daily Skin Care Shoes Under Leadership Of Boots
Boots charts Clearasil course
Boots names Japanese distributor for Clearasil
Beiersdorf
Boots
Colgate Brand Acquisitions Interest Downplayed By CEO Mark
BioProgress
Advertisement
UsernamePublicRestriction

Register

RS008575

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel